Obstructive sleep apnea expected to affect nearly 77 million u.s. adults by 2050, new resmed study finds

San diego, aug. 27, 2025 (globe newswire) -- resmed (nyse: rmd, asx: rmd), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced the publication of a landmark study in the lancet respiratory medicine projecting a significant rise in obstructive sleep apnea (osa) in the united states over the next three decades due to a variety of factors, including an aging population and increasing body mass index (bmi). the study estimates that by 2050, osa will affect nearly 77 million u.s. adults, representing a relative1 increase of nearly 35% from 2020 and impacting 46% of adults aged 30-69.
RMD Ratings Summary
RMD Quant Ranking